天工国际(00826.HK)附属订粉末冶金分销协议
天工国际(00826.HK)公布,间接全资附属公司天工发展与欧洲特钢产品领先供应商订立粉末冶金独家分销协议。
根据协议,天工发展将向欧洲市场的业务夥伴独家提供各种尺寸的粉末冶金钢产品,而业务夥伴有权於欧洲市场销售该等粉末冶金钢产品。
协议项下总供应量分别为2021年7月1日至2022年6月30日为30至50吨;2022年7月1日至2023年6月30日为50至100吨;2023年7月1日至2024年6月30日为200至300吨;2024年7月1日至2025年6月30日为300至600吨。
公司指,协议将有助於确保对集团新冶金产品需求的稳定,并因此可提升集团粉末冶金生产线投资的盈利能力及回报。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.